NOV Form 144 notes planned sale of 21,435 common shares

Rhea-AI Filing Summary

NOV has a Form 144 notice indicating that a holder plans to sell 21435 shares of common stock, with an aggregate market value of $316078.37. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 11/24/2025, with 364752877 shares of the same class outstanding. The securities being sold were acquired as restricted stock from the issuer in three grants on 02/06/2025, 02/15/2025, and 02/23/2025, totaling 5923, 8156, and 7356 shares respectively, each noted as having payment marked "Not Applicable."

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21435	316078.37	364752877	11/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2025	Restricted Stock	Issuer			5923	02/23/2025	Not Applicable
Common	02/06/2025	Restricted Stock	Issuer			7356	02/06/2025	Not Applicable
Common	02/15/2025	Restricted Stock	Issuer			8156	02/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does NOV's latest Form 144 filing disclose?

The Form 144 discloses that a holder of NOV common stock has notified the SEC of an intended sale of 21435 shares under Rule 144.

How many NOV (NOV) shares are planned to be sold under this Form 144?

The notice covers the planned sale of 21435 shares of NOV common stock, with an aggregate market value reported as $316078.37.

On which exchange and through which broker will the NOV shares be sold?

The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC, Executive Financial Services, based on the information provided.

When is the approximate sale date for the NOV shares in this Form 144?

The Form 144 lists an approximate sale date of 11/24/2025 for the 21435 NOV common shares.

How were the NOV shares being sold under Form 144 originally acquired?

The shares were acquired as restricted stock from the issuer on three dates: 5923 shares on 02/23/2025, 7356 shares on 02/06/2025, and 8156 shares on 02/15/2025, each with payment noted as "Not Applicable."

How many NOV shares of this class are outstanding according to the Form 144?

The filing reports 364752877 shares of the same class of NOV common stock as outstanding at the time referenced.